JP2524783B2 - Liver function improver for livestock and poultry - Google Patents

Liver function improver for livestock and poultry

Info

Publication number
JP2524783B2
JP2524783B2 JP62304493A JP30449387A JP2524783B2 JP 2524783 B2 JP2524783 B2 JP 2524783B2 JP 62304493 A JP62304493 A JP 62304493A JP 30449387 A JP30449387 A JP 30449387A JP 2524783 B2 JP2524783 B2 JP 2524783B2
Authority
JP
Japan
Prior art keywords
weight
liver
poultry
livestock
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP62304493A
Other languages
Japanese (ja)
Other versions
JPH01146823A (en
Inventor
久也 須田
正大 堀
英彦 工藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP62304493A priority Critical patent/JP2524783B2/en
Publication of JPH01146823A publication Critical patent/JPH01146823A/en
Application granted granted Critical
Publication of JP2524783B2 publication Critical patent/JP2524783B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は家畜・家禽の肝機能改善剤に関する。TECHNICAL FIELD The present invention relates to a liver function improving agent for livestock and poultry.

〔従来の技術〕[Conventional technology]

近年、畜産業界では家畜・家禽の肝臓疾患に起因する
疾病とその経済的損失が問題となっている。
In recent years, diseases caused by liver diseases of livestock and poultry and their economic losses have become a problem in the livestock industry.

例えば、泌乳初期の高泌乳牛においては乳生産が食欲
を凌駕し、それによるエネルギー不足を補うために、体
脂肪の動員が活発になり、その結果、脂肪肝に発展し種
々の代謝障害や感染症を引き起こしている。
For example, in high-lactation cows in the early stage of lactation, milk production surpasses appetite, and in order to compensate for the lack of energy, mobilization of body fat becomes active, resulting in the development of fatty liver and various metabolic disorders and infections. Is causing the disease.

さらには妊娠末期に肥満している牛においては分娩後
に脂肪肝等の肝機能障害を起し易く、その結果、卵巣の
活動開始と排卵が遅延し、発情・受胎が遅れてしまうこ
とが知られている。
Furthermore, it is known that cattle that are obese at the end of pregnancy are prone to hepatic dysfunction such as fatty liver after calving, and as a result, the onset of ovarian activity and ovulation are delayed, and estrus and conception are delayed. ing.

また鶏等の家禽においては、濃厚飼料の給餌により、
肝臓に大きな負担がかかり、肝機能障害を起こし産卵率
の低下、肝臓への脂肪蓄積による黄色化などの経済的損
失を招いている。
Also, in poultry such as chickens, by feeding concentrated feed,
It puts a heavy burden on the liver and causes hepatic dysfunction, resulting in economic loss such as a decrease in egg laying rate and yellowing due to fat accumulation in the liver.

これらの肝機能障害を改善するために種々の工夫や薬
剤が施されているが未だ完全とは言いにくく、有効性の
高い薬剤が切望されていた。
Various devises and drugs have been applied to improve these liver dysfunctions, but it is still difficult to say that they are complete, and there is a strong demand for a highly effective drug.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

本発明者等は、上記事情に鑑み、植物ステロールを有
効成分とする家畜・家禽の肝機能改善剤を提供しようと
するものである。
In view of the above situation, the present inventors intend to provide a liver function improving agent for livestock and poultry, which contains plant sterol as an active ingredient.

〔問題点を解決するための手段〕[Means for solving problems]

本発明が提供する家畜・家禽の肝機能改善剤の有効成
分である植物ステロールとしては、各種の植物から得ら
れるステロール例えばスチグマステロール、エルゴステ
ロール、5,6−ジヒドロステロール、ブラシカステロー
ル、カンペステロール、α−スピナステロール、β−ス
ピナステロール、γ−スピナステロール、δ−スピナス
テロール、β−シトステロール、γ−シトステロール、
フコステロール、ジモステロール、アスコステロール、
セレビステロール、エピステロール、γ−シトスタノー
ル、フェコステロール、アナステロール、ヒポステロー
ル、コンドリラステロール、スチグマスタノール等があ
げられるが特にβ−シトステロール、スチグマステロー
ル、カンペステロール、γ−シトステロール、ブラシカ
ステロール等が好ましい。これらを一種又は二種以上を
適宜組合せて用いる。また、これらの植物ステロールは
精製品もしくは粗生成物の形態にて用いても良い。
The plant sterol, which is an active ingredient of the liver function improving agent for livestock and poultry provided by the present invention, is a sterol obtained from various plants such as stigmasterol, ergosterol, 5,6-dihydrosterol, brassicasterol, campesterol. , Α-spinasterol, β-spinasterol, γ-spinasterol, δ-spinasterol, β-sitosterol, γ-sitosterol,
Fucosterol, dimosterol, ascosterol,
Examples include cerevisterol, episterol, γ-sitostanol, fecosterol, anasterol, hyposterol, chondrilasterol, stigmasteranol, and the like, but particularly β-sitosterol, stigmasterol, campesterol, γ-sitosterol, brassica. Sterols and the like are preferred. These are used alone or in appropriate combination of two or more. Further, these plant sterols may be used in the form of a purified product or a crude product.

植物ステロールのうち、例えばスチグマステロールは
ダイズ、ヤシ、綿実、インゲン豆、オモダカ等から、カ
ンペステロールはナタネ、小麦、ダイズ、ライ麦等か
ら、β−シトステロールは穀類や高等植物の樹皮、葉部
などに遊離状態、配糖体、脂肪酸エステルなどとして広
く含まれており、γ−シトステロールはエンドウ豆、カ
ラバル豆、米、ダイズ等から得られるが、これらの植物
から油を分取する際に得られる粗植物ステロールでも良
く、又それらの油から、健康食品としてもてはやされて
いる天然ビタミンEを分取した際に得られる粗植物ステ
ロールなどは価格も安価に提供され得ることから経済的
にも大きな利点でもある。
Among plant sterols, for example, stigmasterol is soybean, palm, cottonseed, kidney beans, odaka, and the like, campesterol is rapeseed, wheat, soybean, rye, and the like, β-sitosterol is a bark of cereals and higher plants, and leaves. It is widely contained in free state, glycosides, fatty acid esters, etc., and γ-sitosterol is obtained from peas, caraval beans, rice, soybean, etc., but obtained when fractionating oil from these plants. The crude plant sterols may be used, or the crude plant sterols obtained by fractionating natural Vitamin E, which is used as a health food, from these oils can be provided at a low price and is economically large. It is also an advantage.

本発明の家畜・家禽の肝機能改善剤は、植物ステロー
ル又は粗植物ステロールを生理的に無害な固体又は液体
の希釈剤と混合し又は混合せずに散剤、粉剤、錠剤、カ
プセル剤、顆粒剤、懸濁剤、油剤等に製剤化してもよい
が通常は慣用の飼料成分などに直接混合するか又は希釈
剤中に分散させたものを飼料成分等に添加することによ
り用いられる。
The liver function improving agent for livestock and poultry of the present invention is a powder, a powder, a tablet, a capsule, or a granule, with or without mixing a plant sterol or a crude plant sterol with a physiologically harmless solid or liquid diluent. Although it may be formulated into a suspension, oil, etc., it is usually used by directly mixing it with a conventional feed ingredient or by adding it dispersed in a diluent to the feed ingredient.

その他適宜の補助剤又は添加物、殺菌剤、防腐剤、酵
素剤、抗生物質、乳酸菌製剤等を混合することも出来
る。
Other appropriate auxiliary agents or additives, bactericides, preservatives, enzyme agents, antibiotics, lactic acid bacterium preparations and the like can also be mixed.

本発明の家畜・家禽の肝機能改善剤の使用有効成分量
は、家畜・家禽の種類、品種、体重、年令、性別、投薬
期間、植物ステロールの種類、肝機能障害の状態などに
より異なるが、例えば成牛1頭当り1日1〜200g、好ま
しくは5〜100gの投与により、また鶏1羽当り1日1.0
〜2000mg、好ましくは10〜700mgの投与により、肝機能
障害を改善でき、更には成牛1頭当り1日0.1〜50g、好
ましくは1日0.5〜25gの投与により、また鶏1羽当り1
日0.1〜400mg、好ましくは0.5〜100mgの投与により肝機
能障害を予防できる。
The amount of active ingredient used in the liver function improving agent for livestock / poultry of the present invention varies depending on the type of livestock / poultry, breed, weight, age, sex, dosing period, type of plant sterol, condition of liver dysfunction, etc. , For example, 1 to 200 g / day, preferably 5 to 100 g / day, per adult cow, and 1.0 / day / chicken
-2000 mg, preferably 10-700 mg, can improve liver dysfunction, and further, 0.1-50 g / day, preferably 0.5-25 g / day / adult, and 1 / chicken.
Administration of 0.1 to 400 mg, preferably 0.5 to 100 mg daily can prevent liver dysfunction.

なお、本発明における肝機能改善剤とは障害を起こし
た肝機能の改善剤を意味すると共に肝機能障害の予防剤
をも意味する。
In addition, the liver function improving agent in the present invention means a liver function improving agent having a disorder and also a preventive agent for liver function disorder.

本発明の家畜・家禽の肝機能改善剤は更に毒性が低い
という特徴を有する。
The livestock / poultry liver function-improving agent of the present invention is further characterized by low toxicity.

以下、実施例、試験例を示して本発明を説明する。 Hereinafter, the present invention will be described with reference to Examples and Test Examples.

実施例1 β−シトステロール 22.9重量部 カンペステロール 14.1重量部 ブラシカステロール 7.9重量部 スチグマステロール 5.1重量部 大 豆 粕 50.0重量部 を均一に混合し調製した。Example 1 β-sitosterol 22.9 parts by weight Campesterol 14.1 parts by weight Brush casterol 7.9 parts by weight Stigmasterol 5.1 parts by weight Oatme meal 50.0 parts by weight was uniformly mixed and prepared.

実施例2 β−シトステロール 51.6重量部 スチグマステロール 11.6重量部 カンペステロール 31.8重量部 ブラシカステロール 5.0重量部 を均一に混合し調製した。Example 2 β-sitosterol 51.6 parts by weight Stigmasterol 11.6 parts by weight Campesterol 31.8 parts by weight Brush casterol 5.0 parts by weight were uniformly mixed and prepared.

実施例3 カンペステロール 2重量部 スチグマステロール 1重量部 コーンコブミール 65重量部 脱脂大豆粉 32重量部 を均一に混合し調製した。Example 3 2 parts by weight of campesterol 1 part by weight of stigmasterol 65 parts by weight of corn cob meal 32 parts by weight of defatted soybean flour were uniformly mixed and prepared.

実施例4 粗植物ステロール(綿実油製造時に得られた。)20重量
部 脱脂大豆粉 60重量部 酵 母 20重量部 を均一に混合し、丸剤に調製した。
Example 4 20 parts by weight of crude plant sterol (obtained during production of cottonseed oil) 60 parts by weight of defatted soybean flour 20 parts by weight of fermented mother were uniformly mixed to prepare a pill.

実施例5 粗植物ステロール(大豆油製造時に得られた。植物ステ
ロールとして約15%含有) 20重量部 とうもろこし粉 60重量部 タ ル ク 20重量部 を均一に混合し、粒状に調製した。
Example 5 20 parts by weight of crude plant sterol (obtained during soybean oil production, containing about 15% of plant sterol) 60 parts by weight of corn flour 20 parts by weight of talc were uniformly mixed to prepare granules.

実施例6 粗植物ステロール(実施例4で用いられた粗植物ステロ
ールからビタミンEを分離時に得られた。植物ステロー
ルとして約60%含有) 5重量部 コンコブミール 80重量部 澱 粉 15重量部 を均一に混合し調製した。
Example 6 Crude plant sterols (obtained during the separation of vitamin E from the crude plant sterols used in Example 4. Approximately 60% content as plant sterols) 5 parts by weight Concovmeal 80 parts by weight Starch 15 parts by weight uniformly It was mixed and prepared.

試験例1 分娩後に食欲不振や乳量減少などの症状を呈し、血液
検査及び肝生検の結果、脂肪肝による肝機能障害と診断
された乳牛10頭(産歴平均4.6回、平均体重650kg)を供
試し、二群に分けて第1表に示した飼料を給与し、実施
例1にて調製した製剤を夫々植物ステロールが15g及び3
0gとなるよう1日1回、4週間連続して経口投与した。
なお、対照としては、分娩後脂肪肝等の症状を呈してい
ない正常牛を供試した。
Test Example 1 10 cows with symptoms such as anorexia and milk loss after calving, and as a result of blood test and liver biopsy, diagnosed as hepatic dysfunction due to fatty liver (average of 4.6 births, average weight of 650 kg) , The feeds shown in Table 1 were fed, and the formulation prepared in Example 1 was supplemented with plant sterols of 15 g and 3 respectively.
Oral administration was carried out once a day for 4 consecutive weeks to give 0 g.
As a control, a normal cow that did not exhibit symptoms such as postpartum fatty liver was used.

1週間毎に血液検査を行い、その結果を第2表に示
す。
Blood tests were performed weekly, and the results are shown in Table 2.

試験例2 7日令のブロイラー専用種雌雄各50羽を供試し、第3
表に示す配合飼料にさらに実施例1の製剤を用い植物ス
テロールが各々0.01、0.05、0.25%となるよう添加して
8週令まで不断給餌した。試験終了後全羽屠殺し、肝臓
中の脂質含量を測定し、その結果を第4表に示す。
Test Example 2 A 50-day 7-day-old broiler-specific male and female was tested and tested.
The formulation of Example 1 was further added to the compounded feeds shown in the table so that plant sterols were added at 0.01, 0.05, and 0.25%, respectively, and fed ad libitum until the age of 8 weeks. After the completion of the test, all the birds were slaughtered, the lipid content in the liver was measured, and the results are shown in Table 4.

〔効果〕 第2表の結果より明らかなように、肝機能障害のある
供試牛のいずれもが2〜4週の植物ステロール投与によ
り正常牛と同等の血液像を示し、肝機能が改善されるに
至った。なお、あわせて、植物ステロール投与により乳
量の増加・体細胞数の低下が観察された。
[Effect] As is clear from the results in Table 2, all of the test cows with liver dysfunction showed the same blood image as normal cows by the administration of plant sterol for 2 to 4 weeks, and the liver function was improved. Came to In addition, an increase in milk production and a decrease in somatic cell count were also observed by the administration of plant sterols.

また、第4表に示されるように鶏において植物ステロ
ールを投与することにより、体重、飼料摂取量には差は
なかったが、肝臓脂質含量、肝臓トリグリセライド含
量、脂肪肝スコアの低下が確認でき、鶏の脂肪肝発生を
抑制することができた。
Also, as shown in Table 4, by administering plant sterols in chickens, there was no difference in body weight and feed intake, but a decrease in liver lipid content, liver triglyceride content, fatty liver score could be confirmed, It was possible to suppress the development of fatty liver in chicken.

これらの知見より植物ステロールが家畜・家禽の肝機
能改善剤として肝機能障害の治療及び予防効果を有する
ことが認められた。
From these findings, it was confirmed that plant sterol has a therapeutic and preventive effect on liver dysfunction as a liver function improving agent for livestock and poultry.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】植物ステロールを有効成分とする家畜・家
禽の肝機能改善剤。
1. A hepatic function improving agent for livestock and poultry, which comprises a plant sterol as an active ingredient.
JP62304493A 1987-12-03 1987-12-03 Liver function improver for livestock and poultry Expired - Fee Related JP2524783B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62304493A JP2524783B2 (en) 1987-12-03 1987-12-03 Liver function improver for livestock and poultry

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62304493A JP2524783B2 (en) 1987-12-03 1987-12-03 Liver function improver for livestock and poultry

Publications (2)

Publication Number Publication Date
JPH01146823A JPH01146823A (en) 1989-06-08
JP2524783B2 true JP2524783B2 (en) 1996-08-14

Family

ID=17933698

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62304493A Expired - Fee Related JP2524783B2 (en) 1987-12-03 1987-12-03 Liver function improver for livestock and poultry

Country Status (1)

Country Link
JP (1) JP2524783B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1983989B1 (en) * 2006-02-09 2013-07-03 National Research Council of Canada Combinations of botanical extracts for promoting cardiovascular health
WO2014015467A1 (en) * 2012-07-23 2014-01-30 Nestec S. A. Composition comprising phytosterols and kudzu and its use in the treatment, alleviation or prevention of metabolic disorders

Also Published As

Publication number Publication date
JPH01146823A (en) 1989-06-08

Similar Documents

Publication Publication Date Title
JP2667351B2 (en) Dietary lipid digestion and absorption inhibitors and foods and beverages
US20180318320A1 (en) Composition for preventing, alleviating or treating muscle diseases or improving muscular function
Hajalizadeh et al. The effect of adding fennel (Foeniculum vulgare) seed powder to the diet of fattening lambs on performance, carcass characteristics and liver enzymes
WO2011077800A1 (en) Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
US20200390793A1 (en) Compositions and methods using oleuropein or curcumin for muscle quality and/or muscle mass
EP0460080B1 (en) Orally administerable calcium supplement for cattle
JP2012102055A (en) Therapeutic agent for ovulation disorder, pharmaceutical composition, livestock feed, food composition and cosmetics composition including the same, and therapeutic method for ovulation disorder of domestic animal/fowl
JP3108675B2 (en) Lipid metabolism improver
JPH03219838A (en) Feed for reducing amount of accumulated body fat
JP2524783B2 (en) Liver function improver for livestock and poultry
JPH0458847A (en) Obesity-resistant fat and oil and obesity-resistant food
KR100218235B1 (en) Feed including cla
JP5004446B2 (en) Skin improver
JPS59205320A (en) Preventive and remedy for bovine lipomatosis
WO2021074807A1 (en) Nutritional supplement
JP3248170B2 (en) Food containing chondroitin sulfate protein complex
CN111493251A (en) Solid beverage with synergistic weight-losing effect and preparation and eating methods thereof
JP7134703B2 (en) Adrenal hypofunction inhibitor
JP6560471B1 (en) Bone formation promoter and preventive and / or therapeutic agent for bone metabolic disease using the same
JP2003261445A (en) Agent for suppressing neutral fat level in blood
US5922702A (en) Ecdysones used to improve productivity of ruminants
JPH01285160A (en) Feed for hog-raising
WO2022050308A1 (en) Composition for enhancing nampt gene expression
JP2018168119A (en) Cancer cell proliferation inhibitor
JP2018087172A (en) Lipid burning promoter

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees